Safety Study of Dasatinib With Bortezomib (Velcade) and Dexamethasone for Multiple Myeloma

Safety Study of Dasatinib With Bortezomib (Velcade) and Dexamethasone for Multiple Myeloma

Sponsor(s)

Bristol Myers Squibb

Principal Investigator(s)Jonathan L Kaufman, MD
Dates9/30/2008 - 9/30/2012